A Phase I, Randomized, Single-centered, Double-blinded Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis
Phase of Trial: Phase I
Latest Information Update: 15 Feb 2017
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Cellular Biomedicine Group
- 09 Dec 2016 According to a Cellular Biomedicine Group media release, this trial is expected to complete by the third quarter of 2017.
- 09 Dec 2016 According to a Cellular Biomedicine Group media release, interim results at 12-week presented at the World Stem Cell Summit.
- 09 Dec 2016 Interim results at 12-week published in the Biomedicine Group Media Release